ANG-1009

N/A

Report date: 2022/04/13 17:33:05

NME

Base Information

Drug NameANG-1009

Drug Alias NameANG-1009

ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)

Mechanisms of ActionTopoisomerase II inhibitors

TargetsTopoisomerase II

Therapy Area/IndicationsBrain Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAngiochem Inc

China Registration ClassN/A

Active CompaniesAngiochem Inc

Inactive CompaniesN/A

Active IndicationsBrain Neoplasms

Inactive IndicationsN/A

ATC CodeN/A